FBRX - NASDAQ

Forte Biosciences, Inc.

FBRX·NASDAQ

$16.74

-7.9%

HealthcareBiotechnology

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$232.47M

EPS-4.7100

P/E Ratio-3.55

Earnings Date08/13/2026

fbrx

Total Assets

Last Annual Value

82.78M

3-Year CAGR

25%

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Forte Biosciences, Inc. Competitors Analysis of Total Assets

FBRX · NASDAQ

Company	Total Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Forte Biosciences, Inc. NASDAQ:FBRX	82.78M	28.5%	13.8%	8.9%
Nkarta, Inc. NASDAQ:NKTX	404.21M	2.2%	8.1%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	61.88M	-8.8%	-16.2%	3.5%
Seres Therapeutics, Inc. NASDAQ:MCRB	138.19M	-27.2%	-17.2%	-6.6%
Tonix Pharmaceuticals Holding Corp. NASDAQ:TNXP	277.17M	21.5%	2.8%	26.0%
Actuate Therapeutics Inc NASDAQ:ACTU	14.04M	67.3%	N/A	N/A
Applied Therapeutics, Inc. NASDAQ:APLT	86.69M	16.5%	-0.7%	N/A
Fate Therapeutics, Inc. NASDAQ:FATE	318.94M	-14.3%	-19.1%	12.9%
PepGen Inc. NASDAQ:PEPG	173.91M	6.7%	3.9%	N/A
Alector, Inc. NASDAQ:ALEC	293.24M	-22.2%	-18.5%	18.4%
Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP	168.19M	81.2%	9.3%	25.1%

Forte Biosciences, Inc. Fair Value Envelope

FBRX · NASDAQ

Our analysis suggests that FBRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $16.7418, this represents a potential HIDDEN relative to our calculated worth for Forte Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $16.7418

Related Guides

Blog Categories

Continue your FBRX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.